Real-world Study of Avelumab First-line Maintenance Treatment in Patients with Advanced Urothelial Carcinoma in France: Overall Results from the Noninterventional AVENANCE Study and Analysis of Outcomes by Second-line Treatment

Autor:	Barthélémy, Philippe, Thibault, Constance, Fléchon, Aude, Gross-Goupil, Marine, Voog, Eric, Eymard, Jean-Christophe, Abraham, Christine, Chasseray, Matthieu, Lorgis, Véronique, Hilgers, Werner, Gobert, Aurélien, Le Moulec, Sylvestre, Simon, Camille, Nicolas, Emanuel, Escande, Anne, Pouessel, Damien, Mouillet, Guillaume, Josse, Constant, Solbes, Marie-Noelle, Lambert, Prisca, Loriot, Yohann
Zdroj:	European Urology Oncology; 20240101, Issue: Preprints
Abstrakt:	In this noninterventional study of avelumab first-line maintenance treatment in France, results were consistent with JAVELIN Bladder 100 phase 3 trial findings. In exploratory subgroup analyses, patients treated with avelumab followed by second-line enfortumab vedotin had encouraging long-term outcomes.
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect